PH insider Angela Ives receives 1,394 SARs vesting from 08/20/2026

Rhea-AI Filing Summary

Angela R. Ives, Vice President & Controller of Parker-Hannifin Corporation (PH), reported receipt of 1,394 stock appreciation rights (SARs) on 08/20/2025. The SARs have an award price of $742.97, are exercisable beginning 08/20/2026, and expire on 08/19/2035. The report shows the SARs convert into 1,394 shares of common stock at a zero exercise price for reporting purposes and are held directly by the reporting person, resulting in 1,394 shares beneficially owned after the transaction. The award vests in three equal annual installments beginning 08/20/2026. The Form 4 was signed on behalf of Ives by an attorney-in-fact on 08/22/2025.

Positive

• Transparency: The Form 4 discloses the award date, number of SARs, vesting schedule, exercise/award price, exercisable date, expiration date, and beneficial ownership.
• Retention alignment: The SARs vest in three equal annual installments beginning 08/20/2026, aligning management incentives with multi-year performance.

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider officer received 1,394 SARs that vest over three years; this is routine equity compensation for a company officer.

The filing documents an equity-based compensation grant to an officer rather than an open-market trade or disposition. The SARs convert to 1,394 shares of common stock and vest in three equal annual installments starting 08/20/2026, with an exercise/award reference price of $742.97 and an expiration date of 08/19/2035. For investors, this is a standard retention and incentive mechanism for management; it increases potential future dilution by 1,394 shares if exercised, but the grant size is small relative to a large-cap issuer and presents no immediate cash flows or change in control.

Corporate Governance Expert

TL;DR: Grant appears to be routine governance practice; vesting schedule aligns with multi-year retention goals.

The Form 4 shows proper disclosure of the director/officer relationship and the SAR award mechanics, including vesting schedule and exercisability. The award vests in three equal annual tranches beginning 08/20/2026, which is consistent with standard performance/retention structures. The report was executed by an attorney-in-fact and contains clear details on conversion to common stock. No departures from standard disclosure or unusual terms are evident from the filing alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ives Angela R

(Last) (First) (Middle)

6035 PARKLAND BOULEVARD

(Street)

CLEVELAND OH 44124

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Parker-Hannifin Corp [ PH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP & Controller

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Rights	$742.97	08/20/2025		A		1,394		08/20/2026(1)	08/19/2035	Common Stock	1,394	$0	1,394	D

Explanation of Responses:

1. The Stock Appreciation Rights award vests in three equal annual installments beginning 8/20/26.

	/s/Stephanie R. Breitenbach, Attorney-in-Fact	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Angela R. Ives report on Form 4 for Parker-Hannifin (PH)?

She reported receipt of 1,394 stock appreciation rights (SARs) on 08/20/2025, exercisable starting 08/20/2026 and expiring 08/19/2035.

How do the reported SARs convert to common stock?

The SARs are reported as underlying 1,394 shares of common stock with a reported price reference of $742.97 and a reported exercise price of $0 for the underlying shares in the filing.

What is the vesting schedule for the SARs reported on the Form 4?

The award vests in three equal annual installments beginning on 08/20/2026.

Who filed and signed the Form 4 on behalf of the reporting person?

The Form 4 was signed by Stephanie R. Breitenbach, Attorney-in-Fact on 08/22/2025.

Does the Form 4 show a sale or transfer of shares by the reporting person?

No. The filing reports an acquisition (A) of SARs, not a sale or disposition.